Lenvatinib + pembrolizumab treats advanced endometrial cancer
(HealthDay)—For patients with advanced endometrial cancer, lenvatinib plus pembrolizumab results in significantly longer progression-free and overall survival than the physician's choice of chemotherapy, according to a ...
Jan 31, 2022
0
3